Drug Trio May Cut Stroke Severity
Too Soon to Recommend the Drug Mix, Researchers Caution
Larger, longer studies are needed before any recommendations are made, the
researchers note. Here are three reasons for their caution:
- The study doesn't show how the patients fared after leaving the
- The researchers weren't able to adjust for any other illnesses patients may
- Patients weren't randomly assigned to take any (or none) of the drug
An editorial in the journal agrees.
The study is an "important" addition to the "growing evidence
that statins and ACE inhibitors may be useful as neuroprotective agents in the
setting of acute ischemic stroke," but more studies are required, the
The editorialists included Tanya Turan, MD, an assistant professor of
neurology at Emory University.